Rosol Michael Stanley 4
4 · NAVIDEA BIOPHARMACEUTICALS, INC. · Filed Feb 17, 2021
Insider Transaction Report
Form 4
Rosol Michael Stanley
Chief Medical Officer
Transactions
- Award
Stock Option
2021-02-15$0.00/sh+25,000$25→ 25,000 totalExercise: $2.56Exp: 2031-02-15→ Common Stock (25,000 underlying)
Holdings
- 6,816(indirect: By 401(k))
Common Stock
Footnotes (1)
- [F1]Stock options granted pursuant to Issuer's 2014 Amended and Restated Stock Incentive Plan, which vest as to one-third on each of the first three anniversaries of the date of grant.